![Juan Vera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 505 751 $ al 30/06/2026
Juan F.
Vera was the founder of AlloVir, Inc., founded in 2013, where the title held was Director & Chief Product Development Officer from 2014 to 2020.
Dr. Vera is also the founder of Marker Cell Therapy, Inc...
Dr. Vera currently holds the positions of President, CEO, Secretary, Treasurer & Director at Marker Therapeutics, Inc. since 2018.
Dr. Vera is also an Associate Professor at Baylor College of Medicine since 2015.
The education history includes a doctorate degree from Universidad El Bosque.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2026 | 344.048 ( 2,06 % ) | 505 751 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Director Ejecutivo | 01/05/2023 |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
| Empresas | Cargo | Fin |
|---|---|---|
Marker Cell Therapy, Inc.
 Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical stage immuno-oncology therapies | Fundador | - |
| ALLOVIRPAR | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical stage immuno-oncology therapies | Commercial Services |
Universidad El Bosque
 Universidad El Bosque Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
